About this deal
Specialist drug” monographs within BNF Publications: identification and reduced level of detail, see How to use BNF Publications online. Aminoglycosides: pre-treatment screening advice on genetic testing for aminoglycoside exposure posing risk to hearing (advice in relevant monographs; see example in gentamicin).
Changes | About | BNF | NICE
This update contains 7 significant changes, 5 dose changes, 1 new monograph, and 1 deleted preparation. This update contains 12 significant changes, 4 dose changes, 1 classification change, 5 new monographs, 1 new preparation, 1 deleted monograph and 1 deleted preparation. A significant investment from National Institute for Health and Care Excellence (NICE) ensures that, with our partners BMJ Group and Royal College of Paediatrics and Child Health, we support NHS health professionals in the UK with unlimited access to BNF content online through MedicinesComplete, via the BNF + BNFC app and in print.Vaccines update: restructure of Influenza vaccine monograph—creation of monographs for influenza vaccine (live) and influenza vaccine (inactivated). Azithromycin [update to dosing for uncomplicated non-gonococcal urethritis in children aged 12 to 17 years old]. Pholcodine-containing cough and cold medicines: withdrawal from UK market as a precautionary measure [MHRA/CHM advice] (see advice in Aromatic inhalations, cough preparations and systemic nasal decongestants). Selective serotonin re-uptake inhibitors: breast-feeding advice for all drugs in class and individual drug monographs updated (see examples in fluoxetine and sertraline).
BNF) | Pharmaceutical Press British National Formulary (BNF) | Pharmaceutical Press
Calcium chloride, calcium gluconate: potential risk of underdosing with calcium gluconate in severe hyperkalaemia [MHRA/CHM advice] (advice in calcium gluconate). This update contains 6 significant changes, 1 dose change, 2 new monographs, 1 new preparation, 4 deleted monographs, and 1 deleted preparation. Mental Health and Criminal Justice Bridging the Gap by J. Steven Lamberti,Robert L. Weisman,Vivek Furtado This update contains 3 significant changes, 1 dose change, 3 new monographs, and 3 deleted monographs. Drugs that cause first dose hypotension, drugs that cause peripheral neuropathy, and drugs that cause hyponatraemia: pharmacodynamic effects drug groups revalidated and updated; see Appendix 1 interactions.The British National Formulary is published jointly by BMJ and Pharmaceutical Press, the publishing division of Royal Pharmaceutical Society. The BNF for Children is published jointly by BMJ, Pharmaceutical Press, the Royal College of Paediatrics and Child Health and the Neonatal and Paediatric Pharmacy Group.
BNF Publications British National Formulary | BNF Publications
Hyoscine hydrobromide patches ( Scopoderm® 1.5 mg patch or Scopoderm® TTS patch): risk of anticholinergic side effects, including hyperthermia [MHRA/CHM advice]. This update contains 5 significant changes, 2 new monographs, 2 new preparations, 4 deleted monographs and 2 deleted preparations. This update contains 14 significant changes, 5 dose changes, 1 new monograph, 4 new preparations, 2 deleted monographs and 1 deleted preparation. Janus kinase (JAK) inhibitors: new measures to reduce risks of major cardiovascular events, malignancy, venous thromboembolism, serious infections and increased mortality [MHRA/CHM advice] (advice in abrocitinib, baricitinib, filgotinib, tofacitinib, upadacitinib; see example in tofacitinib).Learn how treatment guidance from Palliative Care Formulary can support health professionals to manage cancer-related neuropathic pain.